Nonallergic Rhinitis Market Expected to Grow with a Healthy CAGR During 2023

The Global Nonallergic Rhinitis Market is expected to grow at a CAGR of 5.3% during the forecast period. Prevalence of nonallergic rhinitis is on the rise across the globe, especially in the developing countries. In addition, increasing research and development activities, and technological advancements to identify the causes and risk factors for infectious diseases is fueling the global nonallergic rhinitis market growth.

Nonallergic Rhinitis, is a condition that refers to the symptoms resembling an allergy, triggered by airborne pollutants, underlying chronic health problems, changes in the weather, certain foods or beverages, some medications. Postnasal drip, runny nose, sneezing, and stuffy nose are major symptoms of nonallergic rhinitis.

About 58 million people in the Americas have allergic rhinitis. By comparison, 19 million have nonallergic rhinitis. In nonallergic rhinitis, swollen blood vessels and fluid build-up in the tissues of the nose leads to inflammation. Allergy test and imaging tests are used for the diagnosis of nonallergic rhinitis, thus differentiating it from allergic rhinitis.

There is also an increasing demand for technologically advanced devices for the diagnosis of nonallergic rhinitis. Increasing awareness about the allergy blood test and allergy skin test also determine the growth of the market. The key players are now focusing on the geographical expansion in the developing regions such as Asia Pacific.

Global Nonallergic Rhinitis Market – Key players

Some of the key players in the global market are Boehringer Ingelheim GmbH (Germany), Novartis (U.S.), GlaxoSmithKline (U.K), Perrigo Company plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Bayer (U.S.), Sanofi (France) and others.

Global Nonallergic Rhinitis Market – Regional Analysis

The Nonallergic Rhinitis Market is found to be increasing in the Americas. Emphasis on healthy lifestyle, and prevention of allergic and nonallergic conditions also influence the growth of the market. Also, increasing demand for technologically advanced diagnostic devices and presence of major market players also influence the growth of the market.

In Europe, the rising prevalence of allergic conditions, and extensive research and development activities on the medical devices drive the market growth. The overall growth of healthcare diagnostic and imaging services also determine the growth of the market. Germany, U.K and France are the major contributors to the growth of the market owing to rising emphasis on the diagnosis and treatment of nonallergic conditions and strengthening healthcare system.

In Asia Pacific, rising awareness about the nonallergic rhinitis, its diagnosis, and treatment are major drivers for the growth of the market. Additionally, increasing healthcare expenditure, and overall demand for medical devices also accelerate the market. India & China are the largest contributors to the growth of the market owing rising emphasis on treatment of chronic diseases and increasing government support.

In the Middle East & Africa, the market is expected to show steady growth owing to low technology penetration, and rising prevalence of chronic diseases. The Middle East is the largest market for nonallergic rhinitis owing to availability of specialty services in regions such as the United Arab Emirates, and Saudi Arabia.

Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @

Global Nonallergic Rhinitis Market – Segments

The global nonallergic rhinitis market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of diagnosis, market is segmented into physical examination, allergy testing, imaging test, and others. Allergy testing is further segmented into skin test, and blood test. Imaging test is further segmented into nasal endoscopy, and computerized tomography (CT) Scan.

On the basis of treatment, the market is segmented into nasal sprays, NSAIDs and others.

Nasal sprays is further segmented into saline, corticosteroid, antihistamine, decongestants, and anti-drip anticholinergic.

On the basis of end user, the market is segmented into hospitals & clinics, research centers, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.